In one document, your head spins.
Page 4. “Market Potential”. (COVID boom in telehealth means everything is awesome.)
Page 14. GMV revenue is down in 2020 due to “impact of COVID-19 on our businesses.”
Page 16. Hey, there’s this new thing called COVID-19, ever heard of it? Looks bad.
This is yet another cut-paste red herring F1 that won’t get across the line. It’s 200 pages of red flag. It still talks about Otsana, as if they haven’t gone into liquidation. Go Brendan!
Lucky they bought Telerhythmics and had nothing to do with setting it up, or that would have gone under too.
It’s an achievement to do this badly when the gods hand you COVID. It can’t be a fluke.
And despite telling us in Jan 2020 that clinical trials are done — they never want to seal the deal on China NMPA.
?????
WTAF.
Was the factory nothing but a scheme to obtain a parking space in Guangzhou?
That makes as much sense as anything in this debacle.
They should offer Elizabeth Holmes a seat on the board, see if Theranos can pump some credibility in.
But maybe over on Reddit the figures look better.
- Forums
- ASX - By Stock
- GMV
- GMVD - NASDAQ IPO
GMVD - NASDAQ IPO, page-1187
-
- There are more pages in this discussion • 745 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online